ERBB2 Amplification Detected by Next Generation Sequencing Is Concordant with HER2 Immunohistochemical Expression in Uterine Serous Carcinoma

被引：0
|
作者：
Robinson, Carrie [1 ]
Harrison, Beth [1 ]
Dong, Fei [1 ]
Perry, Caitlin [2 ]
Nucci, Marisa [3 ]
Kolin, David [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Partners Hlth Syst, Somerville, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1109
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lyle, Stephen
    Tse, Julie Y.
    LABORATORY INVESTIGATION, 2018, 98 : 103 - 103
  • [22] Correlation between HER2 testing by immunohistochemistry-ish and ERBB2 determined by next generation sequencing
    Plotkin, Anna
    Olkhov-Mitsel, Ekaterina
    Huang, Weei-Yuarn
    Nofech-Mozes, Sharon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A159 - A160
  • [23] Acral lentiginous melanoma with HER2/ErbB2 amplification
    Marie Donzel
    Olivier Harou
    François Skowron
    Stéphane Dalle
    Françoise Descotes
    Brigitte Balme
    Jonathan Lopez
    European Journal of Dermatology, 2021, 31 : 588 - 590
  • [24] Acral lentiginous melanoma with HER2/ErbB2 amplification
    Donzel, Marie
    Harou, Olivier
    Skowron, Francois
    Dalle, Stephane
    Descotes, Francoise
    Balme, Brigitte
    Lopez, Jonathan
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (04) : 588 - 590
  • [25] Detection ofERBB2amplification in uterine serous carcinoma by next-generation sequencing: an approach highly concordant with standard assays
    Robinson, Carrie L.
    Harrison, Beth T.
    Ligon, Azra H.
    Dong, Fei
    Maffeis, Valeria
    Matulonis, Ursula
    Nucci, Marisa R.
    Kolin, David L.
    MODERN PATHOLOGY, 2021, 34 (03) : 603 - 612
  • [26] HER2 expression by next-generation sequencing versus immunohistochemistry in uterine serous carcinoma at a major gynecologic oncology referral center in the Southeast
    Blackman, Alexandra
    Oesch, Sydney
    Rogers, Ralph
    Creasman, William
    Graybill, Whitney
    Kohler, Matthew
    Harold, Justin
    Orellana, Taylor
    Orr, Brian
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S179 - S179
  • [27] Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer
    Xia, Daniel
    Kuo, Frank
    Dillon, Deborah
    MODERN PATHOLOGY, 2018, 31 : 113 - 113
  • [28] Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer
    Xia, Daniel
    Kuo, Frank
    Dillon, Deborah
    LABORATORY INVESTIGATION, 2018, 98 : 113 - 113
  • [29] MOLECULAR LANDSCAPE OF ERBB2/HER2 GENE AMPLIFICATION AMONG PATIENTS WITH ENDOMETRIAL CARCINOMA
    Nasioudis, Dimitrios
    Latif, Nawar
    Haggerty, Ashley
    Cory, Lori
    Kim, Sarah
    Morgan, Mark
    Simpkins, Fiona
    Ko, Emily
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A26 - A26
  • [30] Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma
    Hagemann, Ian S.
    Bridge, Julia A.
    Tafe, Laura J.
    Hameed, Meera R.
    Moncur, Joel T.
    Bellizzi, Andrew M.
    Dolan, Michelle
    Vasalos, Patricia
    Kane, Megan E.
    Souers, Rhona J.
    Yemelyanova, Anna
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (10) : 1148 - 1157
12345